STXS
Stereotaxis, Inc.
Key Financials
Operating Income
$-22112000
↑ 10.6%
Gross Profit
$17.1M
↑ 17.0%
Net Income
$-21643000
↑ 10.0%
Revenue
$32.4M
↑ 20.3%
EPS (Diluted)
$-0.25
↑ 16.7%
Total Assets
$52.3M
↑ 11.8%
Total Liabilities
$33.5M
↓ 5.0%
Cash & Equivalents
$13.4M
↑ 9.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SD | 5/29/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 4 | 4/13/2026 | View on SEC |
| 10-K/A | 4/3/2026 | View on SEC |
| DEFA14A | 4/3/2026 | View on SEC |
| DEF 14A | 4/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | STXS |
| Company Name | Stereotaxis, Inc. |
| CIK | 1289340 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 314-678-6100 |